Goldman Sachs has reined in risk-taking due to market volatility triggered by Donald Trump’s trade war and fears that rising ...

Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Viatris (NasdaqGS:VTRS) with a Neutral ...

Fintel reports that on June 6, 2025, Goldman Sachs upgraded their outlook for MasTec (NYSE:MTZ) from Neutral to Buy. Analyst ...

Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

The housing market remains constrained in 2025. Goldman said mortgage rates will stay elevated, raising its year-end target ...

Jubilant Bhartia Group received $600 million from Goldman Sachs to acquire a 40 per cent stake in Coca-Cola's Indian bottling ...

In a significant secondary market move, prominent investors like SBI Mutual Fund and Goldman Sachs acquired a 1.8% stake in ...

Goldman Sachs provides $600M hybrid funding for Jubilant Bhartia’s $1.5B stake buy in Coca-Cola’s India bottling unit; deal ...

Goldman Sachs lowered Tesla's target price citing weak deliveries in Europe and US. Tesla stock fell 14% on Thursday, wiping ...

Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...

Goldman Sachs has added these three stocks to its Conviction List. They all have at least 20% upside potential to the analyst ...

SBI MF, Morgan Stanley and Goldman Sachs, among others, on Friday cumulatively bought a 1.8 per cent stake in Bajaj Finserv ...